Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers V > Headlines for Valeant Pharmaceuticals International Inc. > News item |
High yield rebounds as week begins; Valeant paper fades; Cablevision, Altice climb higher
By Paul A. Harris and Stephanie N. Rotondo
Portland, Ore., Oct. 5 – After weeks of being under pressure, the high-yield bond market rallied in Monday trading.
“Everything was up,” a trader said. “Up, up, up.”
One notable trend-bucker was Valeant Pharmaceuticals International Inc. Its 6 1/8% notes due 2025 were seen off 1˝ points at 96.
As for gainers, Cablevision Systems Corp.’s recently priced issues were moving up. The company priced $4.8 billion of notes in three tranches on Friday. Proceeds from that offering will be used to pay off existing debt and to fund a merger with Altice SA.
Both Cablevision and Altice saw their older debt also rising.
Also in the telecommunications space, Sprint Corp. “rebounded smartly,” according to a trader.
Bombardier Inc. was another name looking to climb higher during the session. Over the weekend, it was reported that the aircraft manufacturer was looking to Quebec’s public pension managers for a potential investment. Early Monday, Scotiabank put out a report that claimed the company could run out of cash by mid-2016.
In the primary, no deals were priced or announced during Monday's session, the sixth to pass without a dollar-denominated junk deal pricing.
There is just one deal on the active calendar, market sources say.
SunOpta Foods Inc. has been marketing a $330 million offering of senior secured second-lien notes due 2022 (B3/B) during the past week. The deal is set to price this week.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.